GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 726 filers reported holding GLAXOSMITHKLINE PLC in Q4 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $854,000 | +52.2% | 19,710 | +42.4% | 0.16% | +46.4% |
Q1 2016 | $561,000 | +14.7% | 13,843 | +14.0% | 0.11% | +17.9% |
Q4 2015 | $489,000 | -8.1% | 12,140 | -12.4% | 0.10% | -11.2% |
Q3 2015 | $532,000 | -5.2% | 13,858 | +2.8% | 0.11% | +3.9% |
Q2 2015 | $561,000 | +2.7% | 13,475 | +13.7% | 0.10% | +1.0% |
Q1 2015 | $546,000 | +8.8% | 11,850 | +0.9% | 0.10% | +6.2% |
Q4 2014 | $502,000 | +14.4% | 11,746 | +23.0% | 0.10% | +11.6% |
Q3 2014 | $439,000 | +0.5% | 9,553 | +16.7% | 0.09% | +21.1% |
Q2 2014 | $437,000 | 0.0% | 8,188 | 0.0% | 0.07% | -24.5% |
Q1 2014 | $437,000 | +6.6% | 8,188 | +6.6% | 0.09% | -1.1% |
Q4 2013 | $410,000 | +13.6% | 7,681 | +6.6% | 0.10% | +2.2% |
Q3 2013 | $361,000 | +8.4% | 7,204 | +8.0% | 0.09% | -8.8% |
Q2 2013 | $333,000 | – | 6,669 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |